BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis-Reference-Cited by-同舟云学术

BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis

Published:2015-10-05 Issue:12 Volume:14 Page:2762-2772
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Sanderson Michael P.,Apgar Joshua,Garin-Chesa Pilar,Hofmann Marco H.,Kessler Dirk,Quant Jens,Savchenko Alexander,Schaaf Otmar,Treu Matthias,Tye Heather,Zahn Stephan K.,Zoephel Andreas,Haaksma Eric,Adolf Günther R.,Kraut Norbert

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targets of formononetin for treating prostate cancer at the single-cell level;Aging;2024-06-13

2. Berberine modulates cardiovascular diseases as a multitarget-mediated alkaloid with insights into its downstream signals using in silico prospective screening approaches;Saudi Journal of Biological Sciences;2024-05

3. The Insulin-like Growth Factor System and Colorectal Cancer;Life;2022-08-20

4. Effects of early low temperature exposure on the growth, glycolipid metabolism and growth hormone (gh) gene methylation in the late stage of Chinese perch (Siniperca chuatsi);Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology;2022-04

5. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma;Neuro-Oncology;2022-02-25